Our results show significant differences in biomarkers’ levels between AS patients and controls as well as significant correlations between ATX, GDF-15, TM levels, and parameters of AS severity, providing insights into the underlying pathophysiological mechanisms and their potential clinical implications. The gene discussed is GDF15; the disease is aortic stenosis.